“With this study, we’ve found a way to potentially harness microglia themselves to treat those diseases,” said Mathew Blurton-Jones of UCI (clockwise from upper left), pictured with Jean Paul Chadarevian of UCI, and Frederick “Chris” Bennett and Sonia Lombroso of Penn.
Combating Alzheimer’s and other neurodegenerative diseases by inserting healthy new immune cells into the brain has taken a leap toward reality.
Neuroscientists at the University of California, Irvine and the University of Pennsylvania have found a way to safely thwart the brain’s resistance to them, vaulting a key hurdle in the quest.
Their discovery about brain cells called microglia heralds myriad possibilities for treating and even preventing neurodegenerative disorders. The team’s paper appears in the Journal of Experimental Medicine.
Link to study: https://rupress.org/jem/article/220/3/e20220857/213788/Engineering-an-inhibitor-resistant-human-CSF1R
When microglia are healthy, they serve as the central nervous system’s resident front-line disease warriors. “However, there is overwhelming evidence that they can become dysfunctional in many neurological conditions,” said Mathew Blurton-Jones, UCI professor of neurobiology & behavior and study co-lead author. “Until recently, scientists have mainly been looking at the mechanisms that drive microglial dysfunction and trying to find drugs to change their activity. But with this study, we’ve found a way to potentially harness microglia themselves to treat those diseases.”
Frederick “Chris” Bennett, assistant professor of psychiatry at Penn and co-lead author, added: “There is an obstacle because once our own microglia develop in the location where they are supposed to be in our brains, they don’t give up that space. They block the ability to deliver new cells that would take their place. If you want to insert donor microglia, you have to deplete the host microglia to open up room.”
Bennett and his laboratory partnered with Blurton-Jones and his lab on the project.
Microglia depend on signaling by a protein on their surface called CSF1R for their survival. The FDA-approved cancer drug pexidartinib has been found to block that signaling, killing them. This process would seem to offer a way to clear space in the brain to insert healthy donor microglia. However, there is a dilemma – unless the pexidartinib is stopped before the donor microglia are added, it will eliminate them, too. But once the drug is terminated, the host microglia regenerate too fast to effectively put in the donor cells.
This quandary has challenged efforts to treat people with certain rare and severe neurologic conditions. One is Krabbe disease, in which the body’s cells can’t digest certain fats that are highly abundant in the brain. Currently, clinicians use bone marrow transplantation and chemotherapy to try to introduce new immune cells similar to microglia into the brain. But this approach can be toxic and must be carried out before Krabbe symptoms manifest.
“Our team believed that if we could overcome the brain’s resistance to accepting new microglia, we could successfully transplant them into patients using a safer, more effective process in order to target a great number of diseases,” said co-first author Sonia Lombroso, a Penn Ph.D. student and member of the Bennett Lab. “We decided to investigate whether we could make the donor microglia resistant to the drug that eliminates their host counterparts.”
The researchers used CRISPR gene-editing technology to create one amino acid mutation, known as G795A, which they introduced into donor microglia produced from human stem cells or a mouse microglial cell line. Then they injected the donor microglia into humanized rodent models while administering pexidartinib, with exciting results.
“We discovered that this one small mutation caused the donor microglia to resist the drug and thrive, while the host microglia continued to die off,” said co-first author Jean Paul Chadarevian, a UCI Ph.D. student who is a member of the Blurton-Jones Lab. “This finding could lead to many options for developing new microglial-based treatments. Pexidartinib is already approved for clinical use and appears to be relatively well tolerated by patients.”
Approaches could range from fighting disease by replacing dysfunctional microglia with healthy ones to designing microglia that can recognize imminent threats and strike against them with therapeutic proteins before they cause harm.
The UCI-Penn team believes treatments based on this kind of microglial method could be developed within a decade. Their next investigations include studying in rodent models how to use the approach to attack the brain plaques associated with Alzheimer’s and to counter Krabbe and other similar diseases.
Original Article: Study finds how our brains turn into smarter disease fighters
More from: University of California Irvine | University of Pennsylvania
The Latest Updates from Bing News
Go deeper with Bing News on:
Inserting healthy immune cells into the brain
- How ultrasound and microbubbles could deliver immunotherapy to the brain
Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. Treatments are limited by the blood–brain barrier, a unique ...
- Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an ...
- New mRNA cancer vaccine helps immune system fight deadly brain tumors
Researchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the body's immune system to attack and potentially treat glioblastoma, a deadly form of brain cancer.
- Brain Injury News
In a new study, AI processed text from health histories ... levels of iron in areas of the brain, which is a sign of injury to brain cells, according to a ... Immune Genes Are Altered in ...
- Novel mRNA Vaccine Shows Promise Against Deadly Brain Cancer
Researchers introduced a new mRNA cancer vaccine that rapidly activates the immune system against glioblastoma, the deadliest form of brain tumor.
Go deeper with Bing News on:
Microglial-based treatments
- The Best Flea Treatments for Cats and Dogs
So consult your own vet: They are the best source to advise you on the right treatment based on your pet’s medical history and pest prevalence in your area. If you’re looking for a medication ...
- Analyst Endorses Vigil Neuroscience’s VGL101 with Buy Rating Amid Promising Preliminary Data and Potential Disease Modification
Vigil Neuroscience Inc (VIGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
- Microbiome studies help explore treatments for genetic disorders
A collaboration has led to the identification, in a bacterium of the intestine, of new CRISPR-Cas9 molecules that could have a clinical potential to treat genetic diseases such as retinitis pigmentosa ...
- Gut-Brain Treatment Goes Viral
It’s not just gut bacteria that connect our guts to our brains. Tiny viruses also have an outsized role to play.
- Treatment Centers in 94547
Our programs integrate evidence-based treatment methods with a spiritual and holistic approach to recovery in order to help our clients build long-lasting and integrative support networks for ...